Financhill
Sell
37

RWEOY Quote, Financials, Valuation and Earnings

Last price:
$29.35
Seasonality move :
-1.19%
Day range:
$29.03 - $29.47
52-week range:
$29.00 - $45.63
Dividend yield:
3.66%
P/E ratio:
7.09x
P/S ratio:
0.85x
P/B ratio:
0.59x
Volume:
165.3K
Avg. volume:
197.4K
1-year change:
-33.11%
Market cap:
$21.8B
Revenue:
$30.9B
EPS (TTM):
$4.14
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $14.7B $15.6B $29.1B $40.5B $30.9B
Revenue Growth (YoY) -7.18% 6.39% 85.98% 39.35% -23.66%
 
Cost of Revenues $10.6B $11.7B $21.6B $33.4B $22.2B
Gross Profit $4.1B $4B $7.5B $7.1B $8.8B
Gross Profit Margin 27.73% 25.34% 25.81% 17.56% 28.31%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $446.7M $495.6M $537.2M $554.7M $893.2M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $5.8B $6.3B $5.4B $7.7B $9.2B
Operating Income -$1.7B -$2.3B $2.1B -$537.8M -$397.3M
 
Net Interest Expenses $1.1B $518.5M $15.4M -- $515.3M
EBT. Incl. Unusual Items -$841.9M $1.4B $1.8B $754M $4.3B
Earnings of Discontinued Ops. $11B $252.4M -- -- --
Income Tax Expense -$103M $429.4M $816.4M -$2.4B $2.6B
Net Income to Company -$738.9M $1B $984.4M $3.2B $1.7B
 
Minority Interest in Earnings -$719.8M -$67.4M -$131.3M -$290M -$159.1M
Net Income to Common Excl Extra Items $9.5B $1.2B $853.1M $2.9B $1.6B
 
Basic EPS (Cont. Ops) $15.47 $1.88 $1.27 $4.14 $2.11
Diluted EPS (Cont. Ops) $15.47 $1.88 $1.27 $4.14 $2.11
Weighted Average Basic Share $614.7M $637.3M $676.2M $691.2M $743.8M
Weighted Average Diluted Share $614.7M $637.3M $676.2M $691.2M $743.8M
 
EBITDA $4B $5.7B $5.2B $3.6B $10.2B
EBIT $433.2M $2.1B $2.4B $1.6B $6.1B
 
Revenue (Reported) $14.7B $15.6B $29.1B $40.5B $30.9B
Operating Income (Reported) -$1.7B -$2.3B $2.1B -$537.8M -$397.3M
Operating Income (Adjusted) $433.2M $2.1B $2.4B $1.6B $6.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $3.4B $5.7B $10.9B $6.6B $5.2B
Revenue Growth (YoY) 17.14% 66.08% 92.04% -39.33% -20.98%
 
Cost of Revenues $1.9B $4.6B $11.9B $5.1B $4B
Gross Profit $1.5B $1.1B -$1B $1.5B $1.2B
Gross Profit Margin 44.64% 18.65% -9.29% 22.81% 23.62%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $950.7M -$1.3B -$534.9M -$337.5M -$508.1M
Operating Income $571.8M $2.3B -$475.5M $1.8B $1.7B
 
Net Interest Expenses $106.4M $93.1M -- -- $433.3M
EBT. Incl. Unusual Items $557.8M $2.3B $16.1M $2.1B $1.4B
Earnings of Discontinued Ops. $200M -- -- -- --
Income Tax Expense $62M $623.7M -$56.4M $104.5M $135.3M
Net Income to Company $563.9M $1.6B -$54.2M $2B $1.4B
 
Minority Interest in Earnings -$12.9M -$37.7M -$53.4M -$14.2M -$33M
Net Income to Common Excl Extra Items $682.9M $1.6B $19.1M $2B $1.3B
 
Basic EPS (Cont. Ops) $1.06 $2.39 $0.03 $2.65 $1.72
Diluted EPS (Cont. Ops) $1.06 $2.39 $0.03 $2.65 $1.72
Weighted Average Basic Share $641.8M $677.8M $633.3M $745.7M $742.9M
Weighted Average Diluted Share $641.8M $677.8M $633.3M $745.7M $742.9M
 
EBITDA $1.8B $3B $986.2M $3.2B $2.9B
EBIT $1.4B $2.6B $526.9M $2.7B $2.3B
 
Revenue (Reported) $3.4B $5.7B $10.9B $6.6B $5.2B
Operating Income (Reported) $571.8M $2.3B -$475.5M $1.8B $1.7B
Operating Income (Adjusted) $1.4B $2.6B $526.9M $2.7B $2.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $15.1B $21B $41.6B $34.2B $25.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $8.8B $18.1B $38.3B $22.7B $19.1B
Gross Profit $6.3B $2.8B $3.4B $11.6B $6.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $5.4B $4.1B $2.9B $9.6B $4.6B
Operating Income $870.8M -$1.3B $488.4M $2B $2B
 
Net Interest Expenses $1.2B -- -- -- $918.5M
EBT. Incl. Unusual Items $1.6B $3.3B $701.1M $2.9B $6.2B
Earnings of Discontinued Ops. $282.8M -- -- -- --
Income Tax Expense $694.3M $571.4M $447.1M -$2.1B $3B
Net Income to Company $988.6M $2.7B -$68.1M $5.1B $3.3B
 
Minority Interest in Earnings -$72.5M -$35.2M -$279.7M -$211.7M -$157.2M
Net Income to Common Excl Extra Items $1.1B $2.7B -$25.7M $4.7B $3.1B
 
Basic EPS (Cont. Ops) $1.81 $3.86 -$0.03 $6.37 $4.14
Diluted EPS (Cont. Ops) $1.81 $3.86 -$0.03 $6.37 $4.14
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $7.5B $9.7B $3.5B $8.4B $11.1B
EBIT $4B $5B $1.6B $4.1B $8.2B
 
Revenue (Reported) $15.1B $21B $41.6B $34.2B $25.6B
Operating Income (Reported) $870.8M -$1.3B $488.4M $2B $2B
Operating Income (Adjusted) $4B $5B $1.6B $4.1B $8.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $10.6B $15.8B $28.7B $22.7B $17.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.9B $12.2B $29.1B $18.5B $12.2B
Gross Profit $4.6B $3.6B -$435.3M $4.2B $5.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.3B $797.8K -$2.4B -$21.8M -$1.4B
Operating Income $2.3B $3.6B $2B $4.2B $6.5B
 
Net Interest Expenses $511.4M $93.1M $180.7M $415.7M $500.7M
EBT. Incl. Unusual Items $2.2B $4.1B $2.9B $4.8B $6.7B
Earnings of Discontinued Ops. $255.1M -- -- -- --
Income Tax Expense $581.4M $747.9M $380.7M $586.5M $943.1M
Net Income to Company $1.7B $3.3B $2.3B $4.2B $5.8B
 
Minority Interest in Earnings -$53.7M -$22.1M -$174.5M -$96.2M -$94.8M
Net Income to Common Excl Extra Items $1.8B $3.3B $2.4B $4.1B $5.6B
 
Basic EPS (Cont. Ops) $2.88 $4.95 $3.49 $5.53 $7.54
Diluted EPS (Cont. Ops) $2.88 $4.95 $3.49 $5.53 $7.54
Weighted Average Basic Share $1.9B $2B $2B $2.2B $2.2B
Weighted Average Diluted Share $1.9B $2B $2B $2.2B $2.2B
 
EBITDA $5B $7.9B $6B $9.6B $10.5B
EBIT $3.7B $5.6B $4.6B $6.8B $8.8B
 
Revenue (Reported) $10.6B $15.8B $28.7B $22.7B $17.4B
Operating Income (Reported) $2.3B $3.6B $2B $4.2B $6.5B
Operating Income (Adjusted) $3.7B $5.6B $4.6B $6.8B $8.8B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $3.6B $5.9B $6.6B $7.5B $7.6B
Short Term Investments $3.6B $5.2B $9.1B $14.4B $8.5B
Accounts Receivable, Net $4.1B $3.7B $7.3B $10.7B $8.4B
Inventory $1.8B $2B $3.2B $4.5B $2.5B
Prepaid Expenses $2B $2.8B $13.8B $9B $2.7B
Other Current Assets $1.3B $1.9B $2.4B $3.1B $2.9B
Total Current Assets $31.6B $33.5B $117.1B $103.2B $59.7B
 
Property Plant And Equipment $21.3B $22B $22.6B $25.5B $31.8B
Long-Term Investments -- -- -- -- --
Goodwill $2.9B $3.2B $3.1B $3B $4.9B
Other Intangibles $2.5B $2.8B $3.6B $3.1B $5.9B
Other Long-Term Assets $2.8B $3.2B $2.7B $2.2B $1.9B
Total Assets $71.7B $75.8B $161.1B $148.6B $117.7B
 
Accounts Payable $3.3B $2.9B $5B $8B $5.7B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.5B $891.7M $1B $1.4B $1.5B
Total Current Liabilities $22B $20.2B $109.8B $85.5B $37.9B
 
Long-Term Debt $2.3B $2.6B $5B $7.5B $11.9B
Capital Leases -- -- -- -- --
Total Liabilities $52.1B $53.7B $141.9B $117.2B $81.1B
 
Common Stock $1.8B $2.1B $2B $1.9B $2.1B
Other Common Equity Adj -- -- -- -- --
Common Equity $19B $21.1B $17.3B $29.6B $34.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $563.4M $970.4M $2B $1.8B $1.7B
Total Equity $19.6B $22.1B $19.2B $31.4B $36.6B
 
Total Liabilities and Equity $71.7B $75.8B $161.1B $148.6B $117.7B
Cash and Short Terms $7.2B $11.1B $15.7B $21.9B $16.2B
Total Debt $2.8B $2.7B $12.1B $16.8B $13B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $4.8B $4.1B $3.3B $8.2B $5B
Short Term Investments $4.3B $4.1B $4.2B $7.8B $7.1B
Accounts Receivable, Net $2.7B $5.2B $8.7B $9.1B $6.1B
Inventory $2B $6.5B $9.6B $2.7B $3.3B
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $26B $124.6B $173.5B $59.9B $41.6B
 
Property Plant And Equipment $22.6B $23B $23.9B $29.9B $39.5B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $67.9B $168.9B $217.1B $115.2B $110.1B
 
Accounts Payable $2.3B $4.3B $7.2B $7.9B $5.2B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $8B $103.4B $158.4B -- --
Total Current Liabilities $15B $119.6B $186.7B $41.7B $26.9B
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $46.6B $149.6B $216.9B $77.5B $70.8B
 
Common Stock $21B $17.2B -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $267.7M $2.1B $1.7B $1.7B $2.2B
Total Equity $21.2B $19.3B $199.5M $37.7B $39.3B
 
Total Liabilities and Equity $67.9B $168.9B $217.1B $115.2B $110.1B
Cash and Short Terms $9.1B $8.2B $7.4B $16B $12.1B
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$738.9M $1B $984.4M $3.2B $1.7B
Depreciation & Amoritzation $3.1B $3.6B $2.5B -$118.1M $4.1B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$1.7B $4.8B $8.6B $2.5B $4.6B
 
Capital Expenditures $2B $2.6B $4.5B $4.7B $10.8B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$816.1M -$5B -$9.2B -$10.4B -$3B
 
Dividends Paid (Ex Special Dividend) -$626.9M -$596.1M -$863.7M -$642.2M -$724.3M
Special Dividend Paid
Long-Term Debt Issued $17.8B $6.3B $19.5B $54.6B $40B
Long-Term Debt Repaid -$15.9B -$6.3B -$16.7B -$47B -$40.6B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$933.7M $6.9M -- -- --
Cash From Financing $250.8M $2B $1.7B $9.1B -$1.7B
 
Beginning Cash (CF) $5.8B $3.7B $5.6B $6.1B $7.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.3B $1.8B $1.2B $1.2B -$142.9M
Ending Cash (CF) $3.6B $5.5B $6.9B $7.4B $7.5B
 
Levered Free Cash Flow -$3.7B $2.2B $4.1B -$2.2B -$6.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $563.9M $1.6B -$54.2M $2B $1.4B
Depreciation & Amoritzation $503.6M $436.3M -$1.9B $527.9M $543.2M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $820.9M -$2B -$1.8B $1.2B $1.5B
 
Capital Expenditures -- -- -- $1.6B $2.8B
Cash Acquisitions -- -- -- $157.9M $49.2M
Cash From Investing -$2.3B -$75.9M $2.7B -$1B -$3.5B
 
Dividends Paid (Ex Special Dividend) -- -- -- -$71.6M -$96.5M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $6.2B $565.8M
Long-Term Debt Repaid -- -- -- -$7.1B $264.5M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $2.2B -$2.6B -- -- --
Cash From Financing $2.2B -$2B -$2.2B -$1.1B $798.3M
 
Beginning Cash (CF) $3.7B $8.5B $4.9B $9.3B $5.9B
Foreign Exchange Rate Adjustment $61.2M -$1.2M $58.5M $5.3M $60.8M
Additions / Reductions $778.6M -$4.1B -$1.3B -$885.4M -$1.1B
Ending Cash (CF) $4.8B $4.2B $3.3B $8.4B $5B
 
Levered Free Cash Flow $820.9M -$2B -$1.8B -$435.7M -$1.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $988.6M $2.7B -$68.1M $5.1B $3.3B
Depreciation & Amoritzation $3.1B $4.4B -$1.2B $4.3B $3B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $2.7B $6.7B $5.8B $4.7B $3.1B
 
Capital Expenditures -- -- -- $3.7B $14B
Cash Acquisitions -- -- -- -$4.9B $3.5B
Cash From Investing -$3.8B -$5.5B -$5.8B -$12.7B -$7.8B
 
Dividends Paid (Ex Special Dividend) -- -- -- -$965.8M -$819.8M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1.6B -- -- -- --
Cash From Financing -$455.1M -$1.9B -$13.7M $12.6B $1.1B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.6B -$682.3M $26.4M $4.5B -$3.6B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.7B $6.7B $5.8B $978M -$10.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.7B $3.3B $2.3B $4.2B $5.8B
Depreciation & Amoritzation $1.3B $2.1B -$1.7B $2.8B $1.6B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $2.1B $4B $1.3B $3.4B $1.9B
 
Capital Expenditures -- -- -- $3.7B $6.9B
Cash Acquisitions -- -- -- -$4.9B -$1.4B
Cash From Investing -$2.4B -$2.9B $475.5M -$1.8B -$6.6B
 
Dividends Paid (Ex Special Dividend) -- -- -- -$965.8M -$1.1B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $37.4B $3.7B
Long-Term Debt Repaid -- -- -- -$37.3B -$1.4B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $1.3B -$2.6B -- -- --
Cash From Financing $1.3B -$2.6B -$4.3B -$826.4M $1.9B
 
Beginning Cash (CF) $10.4B $21.9B $18.6B $24.1B $17.6B
Foreign Exchange Rate Adjustment -$26.9M $53.1M $57.4M $83.8M $127.6M
Additions / Reductions $1.1B -$1.4B -$2.6B $720.8M -$2.8B
Ending Cash (CF) $11.6B $20.4B $15.4B $25B $15.1B
 
Levered Free Cash Flow $2.1B $4B $1.3B -$296.1M -$5B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock